Efficacy of gefitinib for elderly patients with advanced non-small cell lung cancer harboring epidermal growth factor receptor gene mutations: a retrospective analysis.

@article{Uruga2010EfficacyOG,
  title={Efficacy of gefitinib for elderly patients with advanced non-small cell lung cancer harboring epidermal growth factor receptor gene mutations: a retrospective analysis.},
  author={Hironori Uruga and Kazuma Kishi and Takeshi Fujii and Yuka Beika and Takahiro Enomoto and Hisashi Takaya and Atsushi Miyamoto and Nasa Morokawa and Atsuko Kurosaki and Kunihiko Yoshimura},
  journal={Internal medicine},
  year={2010},
  volume={49 2},
  pages={103-7}
}
OBJECTIVE To retrospectively evaluate the efficacy and safety of gefitinib in elderly patients with advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor mutations. METHODS AND PATIENTS Nine patients aged 70 years or older who had advanced NSCLC with mutations of the epidermal growth factor receptor gene were treated with gefitinib, 250 mg daily. Clinical data, types of epidermal growth factor receptor mutations, efficacy and toxicity of gefitinib were… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Similar Papers

Loading similar papers…